Angi Q2 2026 Earnings Call Transcript Released, No Immediate Data to Shift Thesis

What happened

Angi Inc. reported Q2 2026 earnings in a call whose transcript was published on August 6, 2026, though the article provided no financial or strategic details. The DeepValue master report had previously rated Angi a WAIT, emphasizing the need for proof of total revenue inflection and sustained free cash flow before committing capital. Without concrete Q2 figures, the narrative remains anchored to the thesis that Angi’s turnaround hinges on proprietary volume growth offsetting network erosion while AI-driven cost cuts begin to yield margin leverage. Investors must wait for fuller disclosures to assess whether the company’s mid-single-digit revenue growth target for 2026 is on track. Until such data emerges, the current valuation offers no clear margin of safety to change the stance.

Implication

Investors should treat the Q2 2026 call as a placeholder; the absence of detailed figures means the thesis remains data-dependent. Monitoring points from the master report—particularly sequential narrowing of revenue declines, proprietary lead growth, and free cash flow trends—stay paramount. If the transcript later reveals positive revenue and margin momentum, conviction could shift upward, but current opacity favors a continued hold. The aggressive buyback program and looming 2028 debt maturity add balance-sheet risk that requires steady cash generation. Until concrete evidence of a durable top-line recovery appears, the risk-reward does not support adding or reducing exposure.

Thesis delta

The Q2 2026 earnings call transcript release does not alter the investment thesis as no new financial or operational data was disclosed. The rating remains WAIT, contingent on Angi’s ability to return to positive revenue growth and sustain free cash flow through 2026.